Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family is a research paper published in Familial Cancer (2021). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Division of Cancer Epidemiology and Genetics, National Cancer Institute
Grant: ZIACP010201
Division of Cancer Epidemiology and Genetics, National Cancer Institute
Grant: ZIACP101231
Division of Cancer Epidemiology and Genetics, National Cancer Institute
Grant: ZIACP010144
Center for Cancer Research, National Cancer Institute Center
Grant: ZIABC010442
National Health and Medical Research Council of Australia
Grant: 1117663
Improving outcomes from melanoma
National Cancer Institute
Grant: HHSN26120080001E
National Institutes of Health
Grant: 1ZIABC010442-24
Method Development: Efficient Computer Vision Based Algorithms
National Institutes of Health
Grant: 1ZIACP101231-06
Studies of Genetic and Environmental Epidemiology
National Institutes of Health
Grant: 1ZIACP010144-16
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes
National Institutes of Health
Grant: 1ZIACP010201-02
Laboratory of Translational Genomics
FWCI
0.15
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals